James brady joins verona pharma as non-executive director

London and raleigh, n.c., march 14, 2022 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces mr. james brady has joined the board as a non-executive director.
VRNA Ratings Summary
VRNA Quant Ranking